Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Sudheer Kumar Gara
Affiliation
National Cancer Institute, National Institutes of Health
ORCID
Career Start Year
2005
Papers
34
H Index
18
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
37974213
Targeting FAcilitates Chromatin Transcription complex inhibits pleural mesothelioma and enhances immunotherapy.
J Exp Clin Cancer Res
2023
37974213
Targeting FAcilitates Chromatin Transcription complex inhibits pleural mesothelioma and enhances immunotherapy.
J Exp Clin Cancer Res
2023
32927122
UHRF1 Is a Novel Druggable Epigenetic Target in Malignant Pleural Mesothelioma.
J Thorac Oncol
2021
34326811
Co-Occurrence of Familial Non-Medullary Thyroid Cancer (FNMTC) and Hereditary Non-Polyposis Colorectal Cancer (HNPCC) Associated Tumors-A Cohort Study.
Front Endocrinol (Lausanne)
2021
32927122
UHRF1 Is a Novel Druggable Epigenetic Target in Malignant Pleural Mesothelioma.
J Thorac Oncol
2021
34790904
Hookah Smoke Mediates Cancer-Associated Epigenomic and Transcriptomic Signatures in Human Respiratory Epithelial Cells.
JTO Clin Res Rep
2021
34790904
Hookah Smoke Mediates Cancer-Associated Epigenomic and Transcriptomic Signatures in Human Respiratory Epithelial Cells.
JTO Clin Res Rep
2021
34326811
Co-Occurrence of Familial Non-Medullary Thyroid Cancer (FNMTC) and Hereditary Non-Polyposis Colorectal Cancer (HNPCC) Associated Tumors-A Cohort Study.
Front Endocrinol (Lausanne)
2021
31522749
Adrenocortical tumors have a distinct, long, non-coding RNA expression profile and LINC00271 is downregulated in malignancy.
Surgery
2020
31937621
A Combinatorial Strategy for Targeting <i>BRAF</i> <sup>V600E</sup>-Mutant Cancers with BRAF<sup>V600E</sup> Inhibitor (PLX4720) and Tyrosine Kinase Inhibitor (Ponatinib).
Clin Cancer Res
2020
32934779
GATA3 and APOBEC3B are prognostic markers in adrenocortical carcinoma and APOBEC3B is directly transcriptionally regulated by GATA3.
Oncotarget
2020
31522749
Adrenocortical tumors have a distinct, long, non-coding RNA expression profile and LINC00271 is downregulated in malignancy.
Surgery
2020
31937621
A Combinatorial Strategy for Targeting <i>BRAF</i> <sup>V600E</sup>-Mutant Cancers with BRAF<sup>V600E</sup> Inhibitor (PLX4720) and Tyrosine Kinase Inhibitor (Ponatinib).
Clin Cancer Res
2020
32934779
GATA3 and APOBEC3B are prognostic markers in adrenocortical carcinoma and APOBEC3B is directly transcriptionally regulated by GATA3.
Oncotarget
2020
30327187
Do patients with familial nonmedullary thyroid cancer present with more aggressive disease? Implications for initial surgical treatment.
Surgery
2019
31703244
<i>NOP53</i> as A Candidate Modifier Locus for Familial Non-Medullary Thyroid Cancer.
Genes (Basel)
2019
30398411
Lysyl Oxidase Is a Key Player in BRAF/MAPK Pathway-Driven Thyroid Cancer Aggressiveness.
Thyroid
2019
30327187
Do patients with familial nonmedullary thyroid cancer present with more aggressive disease? Implications for initial surgical treatment.
Surgery
2019
30620390
Distinct genome-wide methylation patterns in sporadic and hereditary nonfunctioning pancreatic neuroendocrine tumors.
Cancer
2019
31703244
<i>NOP53</i> as A Candidate Modifier Locus for Familial Non-Medullary Thyroid Cancer.
Genes (Basel)
2019
30398411
Lysyl Oxidase Is a Key Player in BRAF/MAPK Pathway-Driven Thyroid Cancer Aggressiveness.
Thyroid
2019
30620390
Distinct genome-wide methylation patterns in sporadic and hereditary nonfunctioning pancreatic neuroendocrine tumors.
Cancer
2019
29294023
In silico VHL Gene Mutation Analysis and Prognosis of Pancreatic Neuroendocrine Tumors in von Hippel-Lindau Disease.
J Clin Endocrinol Metab
2018
30301885
Metastatic adrenocortical carcinoma displays higher mutation rate and tumor heterogeneity than primary tumors.
Nat Commun
2018
30250647
Synergistic combination of flavopiridol and carfilzomib targets commonly dysregulated pathways in adrenocortical carcinoma and has biomarkers of response.
Oncotarget
2018
29294023
In silico VHL Gene Mutation Analysis and Prognosis of Pancreatic Neuroendocrine Tumors in von Hippel-Lindau Disease.
J Clin Endocrinol Metab
2018
29149451
Transcriptional alterations in hereditary and sporadic nonfunctioning pancreatic neuroendocrine tumors according to genotype.
Cancer
2018
30250647
Synergistic combination of flavopiridol and carfilzomib targets commonly dysregulated pathways in adrenocortical carcinoma and has biomarkers of response.
Oncotarget
2018
30301885
Metastatic adrenocortical carcinoma displays higher mutation rate and tumor heterogeneity than primary tumors.
Nat Commun
2018
29149451
Transcriptional alterations in hereditary and sporadic nonfunctioning pancreatic neuroendocrine tumors according to genotype.
Cancer
2018
28600475
Dual Inhibition of HDAC and Tyrosine Kinase Signaling Pathways with CUDC-907 Inhibits Thyroid Cancer Growth and Metastases.
Clin Cancer Res
2017
28600475
Dual Inhibition of HDAC and Tyrosine Kinase Signaling Pathways with CUDC-907 Inhibits Thyroid Cancer Growth and Metastases.
Clin Cancer Res
2017
29263832
To the editor.
NPJ Genom Med
2017
28114280
RARRES2 functions as a tumor suppressor by promoting β-catenin phosphorylation/degradation and inhibiting p38 phosphorylation in adrenocortical carcinoma.
Oncogene
2017
28114280
RARRES2 functions as a tumor suppressor by promoting β-catenin phosphorylation/degradation and inhibiting p38 phosphorylation in adrenocortical carcinoma.
Oncogene
2017
29263832
To the editor.
NPJ Genom Med
2017
26324161
FDG PET/CT Scan and Functional Adrenal Tumors: A Pilot Study for Lateralization.
World J Surg
2016
26324161
FDG PET/CT Scan and Functional Adrenal Tumors: A Pilot Study for Lateralization.
World J Surg
2016
25488748
miR30a inhibits LOX expression and anaplastic thyroid cancer progression.
Cancer Res
2015
25488748
miR30a inhibits LOX expression and anaplastic thyroid cancer progression.
Cancer Res
2015
25767039
Phase I trial of systemic intravenous infusion of interleukin-13-Pseudomonas exotoxin in patients with metastatic adrenocortical carcinoma.
Cancer Med
2015
26222560
Germline HABP2 Mutation Causing Familial Nonmedullary Thyroid Cancer.
N Engl J Med
2015
26581001
HABP2 Mutation and Nonmedullary Thyroid Cancer.
N Engl J Med
2015
26446994
Integrated genome-wide analysis of genomic changes and gene regulation in human adrenocortical tissue samples.
Nucleic Acids Res
2015
26581001
HABP2 Mutation and Nonmedullary Thyroid Cancer.
N Engl J Med
2015
26446994
Integrated genome-wide analysis of genomic changes and gene regulation in human adrenocortical tissue samples.
Nucleic Acids Res
2015
26222560
Germline HABP2 Mutation Causing Familial Nonmedullary Thyroid Cancer.
N Engl J Med
2015
25767039
Phase I trial of systemic intravenous infusion of interleukin-13-Pseudomonas exotoxin in patients with metastatic adrenocortical carcinoma.
Cancer Med
2015
24563484
A mouse model for dominant collagen VI disorders: heterozygous deletion of Col6a3 Exon 16.
J Biol Chem
2014
24563484
A mouse model for dominant collagen VI disorders: heterozygous deletion of Col6a3 Exon 16.
J Biol Chem
2014
1 - 50 of 68
Column Actions
Search
Recommended Authors
Qi Zhao
University of Science and Technology Liaoning
Career Start Year
2009
Number of shared co-authors
0
Salvatore Piscuoglio
University of Basel
Career Start Year
2008
Number of shared co-authors
0
Mark J Cowley
Children's Cancer Institute, Lowy Cancer Research Centre
Career Start Year
2006
Number of shared co-authors
1
Jochen K Lennerz
Massachusetts General Hospital/Harvard Medical School
Career Start Year
2004
Number of shared co-authors
0
Jianmin Wang
Roswell Park Comprehensive Cancer Center
Career Start Year
2003
Number of shared co-authors
0
Han Si
Hubei Engineering Research Center for Bio-enzyme Catalysis, Hubei University
Career Start Year
2003
Number of shared co-authors
3
Sandya Liyanarachchi
The Ohio State University Comprehensive Cancer Center, Comprehensive Cancer Center
Career Start Year
2002
Number of shared co-authors
2
Yuelin J Zhu
National Cancer Institute, National Institutes of Health
Career Start Year
2002
Number of shared co-authors
20
Yan W Asmann
Mayo Clinic
Career Start Year
2000
Number of shared co-authors
2
Jonathan K Killian
From Foundation Medicine
Career Start Year
1999
Number of shared co-authors
18
Jan Koster
Amsterdam University Medical Centers location AMC
Career Start Year
1999
Number of shared co-authors
0
Dirce Maria Carraro
AC Camargo Cancer Center
Career Start Year
1998
Number of shared co-authors
0
Jianjun Shen
The University of Texas MD Anderson Cancer Center
Career Start Year
1998
Number of shared co-authors
0
Robert L Walker
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year
1997
Number of shared co-authors
18
Lianbo Yu
The Ohio State University
Career Start Year
1997
Number of shared co-authors
0
Agnes Viale
Memorial Sloan Kettering Cancer Center
Career Start Year
1996
Number of shared co-authors
0
Woong-Yang Park
Samsung Genome Institute, Samsung Medical Center
Career Start Year
1995
Number of shared co-authors
0
Marbin Pineda
Center for Cancer Research, National Cancer Institute
Career Start Year
1995
Number of shared co-authors
7
Hidewaki Nakagawa
RIKEN Center for Integrative Medical Sciences
Career Start Year
1994
Number of shared co-authors
1
Tatsuhiro Shibata
Kurume University School of Medicine
Career Start Year
1993
Number of shared co-authors
3
Weei-Yuarn Huang
Nova Scotia Health Authority
Career Start Year
1992
Number of shared co-authors
0
Phillip A Futreal
The University of Texas MD Anderson Cancer Center
Career Start Year
1991
Number of shared co-authors
2
Ming-Hui Wei
Yantai Affiliated Hospital of Binzhou Medical University
Career Start Year
1991
Number of shared co-authors
2
Fredrik Pont??n
Uppsala University
Career Start Year
1991
Number of shared co-authors
0
Sean M Grimmond
The University of Melbourne
Career Start Year
1990
Number of shared co-authors
0
Shrikant Mane
Yale School of Medicine
Career Start Year
1989
Number of shared co-authors
0
Thomas J Giordano
University of Michigan ann arbor
Career Start Year
1989
Number of shared co-authors
6
Katherine L Nathanson
Perelman School of Medicine, University of Pennsylvania, USA Abramson Cancer Center
Career Start Year
1986
Number of shared co-authors
1
Andrew D Cherniack
Dana-Farber Cancer Institute
Career Start Year
1984
Number of shared co-authors
2
Matthew Meyerson
Broad Institute
Career Start Year
1983
Number of shared co-authors
2
row(s) 1 - 30 of 30
Collaborators
Electron Kebebew
Stanford University School of Medicine
Co-authored papers
22
Dhaval Patel
National Cancer Institute, National Institutes of Health
Co-authored papers
11
Naris Nilubol
Center for Cancer Research
Co-authored papers
10
Lisa Zhang
National Institute of Child Health and Development
Co-authored papers
10
Myriem Boufraqech
The University of Texas at Austin
Co-authored papers
9
Martha Quezado
National Cancer Institute (NCI), National Institutes of Health (NIH)
Co-authored papers
6
Kelli Gaskins
Frederick National Laboratory for Cancer Research, National Institutes of Health
Co-authored papers
5
Yi Liu-Chittenden
Department of Biochemistry and Howard Hughes Medical Institute, Stanford University
Co-authored papers
4
Maria J Merino
National Cancer Institute, National Institutes of Health
Co-authored papers
4
Maggie Cam
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers
3
Cuong Hoang-Vu
Center for Cancer Research, National Cancer Institute
Co-authored papers
3
Meenu Jain
Georgia Cancer Center, Augusta University
Co-authored papers
3
David S Schrump
Center for Cancer Research, National Cancer Institute
Co-authored papers
3
Shweta Kotian
Center for Drug Evaluation and Research
Co-authored papers
2
Sunita K Agarwal
National Institute of Diabetes and Digestive and Kidney Diseases
Co-authored papers
2
Mark Raffeld
Center for Cancer Research, National Cancer Institute
Co-authored papers
2
Samira M Sadowski
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers
2
Min Shen
National Center for Advancing Translational Sciences, National Institutes of Health
Co-authored papers
2
Mary Zhang
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers
2
Sean Davis
Johns Hopkins School of Medicine, National Cancer Institute, Princeton University, University of Colorado Anschutz Medical Campus, University of Pittsburgh, University of Washington
Co-authored papers
2
Susan R Davis
Co-authored papers
2
Ryan J Ellis
Memorial Sloan Kettering Cancer Center
Co-authored papers
2
Markku Miettinen
National Cancer Institute
Co-authored papers
2
Sichuan Xi
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers
2
Vivek Shukla
Chalmers University of Technology
Co-authored papers
2
William Marston Linehan
Co-authored papers
1
John A Copland
Mayo Clinic Jacksonville
Co-authored papers
1
Rachel Aufforth
The University of North Carolina
Co-authored papers
1
Giorgio Trinchieri
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers
1
Julie A Hong
National Cancer Institute, National Institutes of Health
Co-authored papers
1
1 - 30